Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: A 65 series of Brazilian patients

Lupus

Volumn 14, Issue 6, 2005, Pages 434-439

  Coelho, Alycia ^a,b   Souto, M I D ^a   Cardoso, C R L ^a   Salgado, D R ^a   Schmal, T R ^a   Cruz, M Waddington ^a   De Souza Papi, J A ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Discoid lupus; Lupus erythematosus; Refractory; Subacute lupus; Thalidomide; Treatment

Indexed keywords

THALIDOMIDE;

ADULT; ARTICLE; BRAZIL; CLINICAL FEATURE; CONTRACEPTION; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ACTIVITY; DISEASE DURATION; DIZZINESS; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROPHYSIOLOGY; FACE EDEMA; FEMALE; FOLLOW UP; HUMAN; HYPERESTHESIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUSCLE CRAMP; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROPATHY; PANNICULITIS; PARESTHESIA; PERIPHERAL EDEMA; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN LUPUS ERYTHEMATOSUS; SKIN TINGLING; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 21844436051     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2124oa     Document Type: Article

References (19)

1. Soares M, Reis L, Papi JAS, Cardoso CRL. Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients. Lupus 2003; 12: 788-794.
2. Knop J, Bonsmann G, Happle R et al. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol 1983; 108: 461-466.
3. Stevens RJ, Andujar C, Edwards CJ et al. Thalidomide in the treatment of cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. Br J Rheumatol 1997; 36: 353-359.
4. Housman TS, Jorizzo JL, McCarty MA, Grummer SE, Fleischer AB, Sutej PG. Low-dose thalidomide therapy for cutaneous lesions of lupus erythematosus. Arch Dermatol 2003; 139: 50-54.
5. Kyriakis KP, Kontochristopoulos GJ, Panteleos DN. Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus. Int J Dermatol 2000; 39: 218-222.
6. Walchner M, Meurer M, Plewing G, Messer G. Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus. Int J Dermatol 2000; 39: 383-388.
7. Calabrese L, Fleischer AB. Thalidomide: current and potential clinical applications. Am J Med 2000; 108: 487-495.
8. Sato EI, Assis LSS, Lorenzi VP, Andrade LEC. Long-term thalidomide use in refractory cutaneous lesions of systemic lupus erythematosus. Rev Assoc Med Bras 1998; 44: 289-293.
9. Ordi-Ros J, Cucurull E, Mauri M, Bujan S, Vilardell M. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. J Rheumatol 2000; 27: 1429-1433.
10. Powell RJ, Gardner-Medwin JNM. Guideline for the clinical use and dispensing of thalidomide. Postgrad Med J 1994; 70: 901-904.
11. Tan EM, Cohen AS, Fries JF et al. The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
12. Sheskin J, Yaar I. Motor-conduction velocity of cubital nerves in patients with leprosy reactions. Summary of a 13-year observation series during thalidomide therapy. Hautarzt 1979; 30: 376-379.
13. Wulff CH, Hoyer H, Asboe-Hansen G, Brodthaden H. Development of polyneuropathy during thalidomide therapy. Br J Dermatol 1985; 112: 475-480.
14. Ochonisky S, Verroust J, Bastuji-Garin S, Gherardi R, Revuz J. Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients. Arch Dermatol 1994; 130: 66-69.
15. Gardner-Medwin JMM, Smith NJ, Powell RJ. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis 1994; 53: 828-832.
16. Hafström T. Polyneuropathy after Neurosedyn (Thalidomide) and its prognosis. Acta Neurol Scand 1967; 43(Suppl. 32): 1-41.
17. Krucke W, Von Hartrott HH, Schöder JM, Thomas E, Gibbels E, Scheid W. Fortschr Neurol Psychiatr Grenzgeb. 1971; 39: 15-50.
18. Chaudhry V, Cornblath DR, Mellitis ED et al. Inter-and intra-examiner reliability of nerve conduction measurements in normal subjects. Ann Neurol 1991; 30: 841-843.
19. Bleasel AF, Tuck RR. Variability of repeated nerve conduction studies. Electroencephlogr Clin Neurophysiol 1991; 81: 417-420.